Menu

Events and conference calls

You are here

  1. Home
  2. Media and investors
  3. MorphoSys events

Company calendar 2020

One of the main goals of the corporate communications function at MorphoSys is to inform stakeholders about the achievements and the developments within the company in an open and timely manner. Please see our full program listings for further details.

Date
Title
Add to Calendar
  1. 03/18/2020

    Year-End Results 2019

  2. 05/06/2020

    First Quarter Interim Statement 2020

  3. 05/27/2020

    Annual General Meeting 2020

  4. 08/05/2020

    Half-Year Report 2020

  5. 11/11/2020

    Third Quarter Interim Statement 2020

Upcoming
conferences

Wed
18
'20
Mar

Year-End Results 2019

add date
Wed
06
'20
May

First Quarter Interim Statement 2020

add date
Wed
27
'20
May

Annual General Meeting 2020

add date
Fri-Tue
29-02
'20
May
Jun

ASCO Annual Meeting

Chicago, Illinois, USA
add date
Wed
05
'20
Aug

Half-Year Report 2020

add date
Wed
11
'20
Nov

Third Quarter Interim Statement 2020

add date

Conference Archive

Date
Title
MP3

2020

  1. 01/15/2020

    Webcast: 38th Annual J.P. Morgan Healthcare Conference

  2. 01/13/2020

    Joint Conference Call MorphoSys and Incyte on the Global Collaboration and License Agreement for Tafasitamab

2019

  1. 12/03/2019

    31st Annual Piper Jaffray Healthcare Conference

  2. 11/25/2019

    Presentation: German Eigenkapitalforum

  3. 10/30/2019

    Conference Call and Webcast: Q3 2019 Financial Results

  4. 09/25/2019

    Presentation: 8th Annual Goldman Sachs and Berenberg German Corporate Conference

  5. 08/27/2019

    Presentation: Commerzbank Sector Conference 2019

  6. 08/07/2019

    Conference Call and Webcast: Q2 2019 Financial Results

  7. 06/25/2019

    Webcast: Meet the Team

  8. 06/22/2019

    Presentation: ICML in Lugano

  9. 06/12/2019

    Presentation: Goldman Sachs 40th Annual Global Healthcare Conference

  10. 06/06/2019

    Presentation: dbAccess

  11. 06/05/2019

    Webcast: Jefferies Healthcare Conference

  12. 05/20/2019

    Conference call: Q&A session on the headline data of tafasitamab (MOR208)

  13. 05/08/2019

    Conference Call and Webcast: Q1 2019 Financial Results

  14. 04/26/2019

    Presentation: Class of 2018 Biotech IPOs Investor Day

  15. 04/16/2019

    Presentation: Kempen Life Sciences Conference

  16. 03/14/2019

    Year-End 2018 Conference Call and Webcast

  17. 02/28/2019

    Webcast: 8th Annual Leerink Partners Global Healthcare Conference